A hub for developing innovative biopharma technologies in Chicago
A Chicago Biomedical Consortium Hub of Innovative Technologies for Entrepreneurship and Science (CBC - HITES)
This study is all about helping researchers in Chicago turn their medical ideas into real treatments for patients, so you could see new therapies and diagnostic tools that improve your health in the future.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10932934 on NIH RePORTER |
What this research studies
This research initiative aims to enhance the biopharmaceutical landscape in Chicago by fostering entrepreneurship and innovation among academic researchers. It focuses on bridging the gap between university-based biomedical projects and the necessary funding and expertise to bring these ideas to clinical application. By creating a multi-campus service center, the project will support researchers in developing new therapies, including small molecules, biologics, and advanced diagnostic tools. Patients may benefit from the resulting advancements in treatment options that emerge from this collaborative effort.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include patients with conditions that could be treated by novel biopharmaceutical therapies.
Not a fit: Patients with conditions that are not addressed by biopharmaceutical innovations may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective biopharmaceutical treatments for various conditions.
How similar studies have performed: Other research initiatives focused on fostering biopharma entrepreneurship have shown promise in enhancing innovation and treatment development, indicating a potential for success in this approach.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Nadig, Satish N — Northwestern University at Chicago
- Study coordinator: Nadig, Satish N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.